Hsbc Holdings PLC Increases Stock Holdings in Aveanna Healthcare Holdings Inc. $AVAH

Hsbc Holdings PLC increased its position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 465.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 76,029 shares of the company’s stock after purchasing an additional 62,584 shares during the period. Hsbc Holdings PLC’s holdings in Aveanna Healthcare were worth $493,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd boosted its holdings in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after purchasing an additional 2,400 shares during the last quarter. Quantbot Technologies LP acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter worth approximately $43,000. Summit Securities Group LLC purchased a new stake in shares of Aveanna Healthcare during the 1st quarter valued at approximately $53,000. Oxford Asset Management LLP purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at approximately $64,000. Finally, Bayesian Capital Management LP acquired a new position in Aveanna Healthcare in the second quarter valued at approximately $85,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on AVAH shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a research report on Wednesday, June 3rd. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Barclays increased their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Finally, Truist Financial raised their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $10.78.

Aveanna Healthcare Stock Performance

Shares of AVAH stock opened at $9.39 on Friday. The firm’s 50 day moving average price is $8.41 and its 200-day moving average price is $7.71. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. Aveanna Healthcare Holdings Inc. has a one year low of $3.73 and a one year high of $10.32. The firm has a market cap of $2.04 billion, a P/E ratio of 7.96, a P/E/G ratio of 0.96 and a beta of 1.89.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The firm had revenue of $647.91 million during the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The company’s revenue was up 15.9% compared to the same quarter last year. As a group, equities research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current year.

Insider Transactions at Aveanna Healthcare

In related news, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the business’s stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $36,455,577.60. Following the sale, the insider owned 13,450,547 shares in the company, valued at approximately $83,931,413.28. The trade was a 30.28% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Paul R. Vigano sold 7,000,000 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $43,680,000.00. Following the transaction, the insider directly owned 252,899 shares in the company, valued at approximately $1,578,089.76. The trade was a 96.51% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 31,305,664 shares of company stock valued at $215,555,910 over the last three months. 5.30% of the stock is currently owned by company insiders.

Aveanna Healthcare Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.